A ‘Barron’s Roundtable’ panel discusses how AI agents are challenging Big Tech’s control. More than 500,000 Walgreens brand eye drop products are being recalled for sterility concerns as part of a broader recall involving nearly 750,000 eye care products. Sterling Pharmaceutical Services LLC, based in Dupo, Illinois, initiated the recall on August 20 due to a “lack of assurance of sterility,” according to a compliance report from the U.S. Food and Drug Administration (FDA). The FDA classified the recall as Class II on September 21. The designation means that use or exposure to the affected products may cause temporary or medically reversible health consequences, while the likelihood of serious health consequences is considered remote. WALMART, JOE’S TRADE FROZEN BERRIES RECALL EXPANDS AFTER E COLI SICK 17 OUTBREAK More than 500,000 Walgreens brand eye drop products are being recalled. (Justin Sullivan/Getty Images, File) Walgreens brand products account for more than 500,000 units in the recall, including approximately 301,114 bottles of Walgreens Lubricating Eye Drops and 199,600 twin packs. The broader recall also includes eye care products distributed under AvKare, Reliable-1 Laboratories, Cameron Pharmaceuticals, TRP The Relief Products and major brands. 120,000 packets of AvKare Sodium Carboxymethylcellulose Ophthalmic Solution, 0.5% Lubricant Eye Drops are affected, including single vials and twin packs. FDA CONCLUDES INVESTIGATION INTO CYCLOSPORA OUTBREAK LINKED TO TAYLOR FARMS ICEBERG LETTUCE SOUVENIR COLLECTION Walgreens’ lubricating eye drops are among eye care products recalled over sterility concerns. (Getty Images) Products distributed by Reliable-1 Laboratories include 5% Sodium Chloride Hypertonicity Ophthalmic Solution and Lubricating Tears. The recall also includes Cameron Pharmaceuticals 0.5% Sodium Carboxymethylcellulose Lubricating Eye Drops, TRP The Relief Products Gentle Eyes Lubricating Eye Drops, and Major LubriFresh PM Nighttime Ointment. Pedestrians walk past a Walgreens store in downtown Chicago. (Christopher Dilts/Bloomberg via Getty Images, File) The FDA says ophthalmic products pose a higher risk because medications applied to the eyes bypass some of the body’s natural defenses. The agency says eye drops should be sterilized to reduce the risk of infection. CLICK HERE TO GET FOX BUSINESS IN GOA A Walgreens representative did not immediately respond to FOX Business’ request for comment.
